<DOC>
	<DOCNO>NCT01972711</DOCNO>
	<brief_summary>This study design evaluate effect single dose SEP-363856 healthy male female volunteer high low schizotype characteristic .</brief_summary>
	<brief_title>Study Assessing SEP-363856 Male Female Volunteers With High Low Schizotype Characteristics</brief_title>
	<detailed_description>The study randomize , double-blind , placebo-controlled functional magnetic resonance imaging ( fMRI ) study effect single dose SEP-363856 amisulpride blood oxygen level dependent ( BOLD ) signal healthy male female volunteer high low schizotype characteristic .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Male female age 18 45 year , inclusive , Day 1 . Subject must healthy determine Investigator , base medical evaluation include medical history , physical examination , laboratory test cardiac monitor within four week randomisation . A subject clinical abnormality laboratory parameter outside reference range population study may include Investigator considers find unlikely introduce additional risk factor interfere study procedure . Subject must normotensive sitting ( 5 minute ) blood pressure range 90 150 mm Hg systolic , inclusive , 60 90 mm Hg diastolic , inclusive , Screening . Subject must sit ( 5 minute ) heart rate ≥ 50 beat per minute Screening . Subject must agree use one follow birth control/contraception method Screening 90 day receive study drug . Female subject child bear potential ( ≤ 65 year ) surgically sterile abstinent , sexually active , must use adequate method contraception addition partner ( ) use barrier method . Male subject female partner ( ) childbearing potential must take appropriate precaution avoid father child use barrier contraception , addition female partner ( ) use another method . Male subject must donate sperm . Acceptable form contraception follow : Barrier method : condom , diaphragm , cervical cap ; spermicide foam , gel , film , cream pessary . Nonhormone contain intrauterine method : intrauterine device system . Other : prescription oral contraceptive , contraceptive injection , contraceptive implant , contraceptive vaginal ring , hormonal intrauterine device , doublebarrier method , contraceptive patch , male partner sterilisation . Subject must normal ECG result , include QTcF &lt; 450msec ( men ) &lt; 470 m ( woman ) ( base Fridericia correction QTcF = QT/RR0.33 ) Screening . Subject must completely fluent English speaker , opinion Investigator , capable complete fMRI behavioural task . Subject must righthanded . Subject must acceptable weight define BMI ( weight [ kg ] /height [ ] ² ) range 18 35 kg/m² , inclusive Screening . Subject must nonsmoker light smoker ( ≤ 10 cigarette per day ) . Subject must sign informed consent form prior first studyrelated procedure indicate understand purpose procedure require study willing participate study . Subject low schizotypy group must SPQ score &lt; 10 Screening . Subject high schizotypy group must SPQ score &gt; 43 Screening Subject history alcohol substance dependence within last 12 month Screening . Subject positive urine drug screen Screening Day 1 . One retest within 1 3 day permit positive result believe due licence opiatebased medication ingestion poppy seed . In event , retest result use assess entry criterion must complete prior randomisation . Subject positive alcohol breath test Screening Day 1 . Female subject positive pregnancy test Screening Day 1 . Female subject currently pregnant try get pregnant currently breast feed . Subject consumes large amount caffeinated drink ( 8 cup standard caffeinated drink ( tea , instant coffee ) 6 cup strong coffee drink contain methylxanthines coca cola Red Bull per day ) . Subject relevant history , presence upon clinical examination , cardiac , ophthalmologic , pulmonary , endocrine ( diabetes ) , blood disease , gastrointestinal , hepatic renal disease condition opinion Investigator could interfere test procedure . Subject history cancer , except basal cell Stage 1 squamous cell carcinoma skin remission least 5 year prior Day 1 . Subject meet diagnostic criterion schizophrenia , psychotic disorder , determine SCIDI Screening Subject history , present ( opinion Investigator ) , significant neurological psychiatric condition ( stroke , traumatic brain injury , depression , seizure , space occupy lesion , multiple sclerosis , Parkinson 's disease , vascular dementia , transient ischemic attack , schizophrenia , blackouts require hospitalisation ) . Subject history positive HIV test . Subject history , current condition , migraine headache undergone operation head . Subject significant hearing impairment , opinion Investigator , may interfere performance behavioural task fMRI task . Subject significant visual impairment include colour blindness , history ocular treatment include corrective laser eye surgery , ongoing condition , opinion Investigator may interfere performance behavioural task fMRI task . Subject receive prescribed medication within 28 day prior Day 1 ( apart contraceptive pill ) . Subjects take prescription medication may still enter study , , opinion Investigator , medication receive interfere study procedure compromise safety ( see Section 10.2 , Concomitant Medications ) . Subject received nonprescription medication , include supplement vitamin herbal supplement within 48 hour prior Day 1 ( apart paracetamol ) . Subjects take nonprescription medication may still enter study , , opinion Investigator , medication receive interfere study procedure compromise safety ( see Section 10.2 , Concomitant Medications ) . Subject receive experimental drug / use experimental medical device within 30 day randomisation within period le 5 time drug 's halflife , whichever longer . Subject know hypersensitivity SEP363856 amisulpride excipients . Subject history severe drug allergy hypersensitivity . Subject unable unwilling comply study procedure , include study prohibition restriction ( see Section 10.2 , Concomitant Medications Section 10.3 , Restrictions ) . Subject previous experience ETB . Subject diagnosis dyslexia . Subject history claustrophobia inability tolerate scanner environment . Subject fulfills MRI contraindication standard site radiography screen questionnaire ( e.g . history surgery involve metal implant ) . Subject clinically relevant structural brain abnormality determine prior MRI scan . Subject plan medical treatment within study period might interfere study procedure . Subject unlikely comply clinical study protocol unsuitable reason , opinion Investigator . Subject staff member relative staff member , subordinate relationship Investigator . Subject answer `` yes '' `` Suicidal Ideation '' Items 4 5 CSSRS .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>